GlassScriptPhysician profile
David L Parker
NPI 1639600174
$11,856.53
in general payments reported to CMS, 2019-2025
11 companies · $2,497 in 2025
The $2,497 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,282 · 2023: $3,660 · 2024: $4,418 · 2025: $2,497.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $7,895 · Food and Beverage: $2,679.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $7,895.49 |
| Food and Beverage | $2,679.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $4,972.90 | 2023-2025 | Mako, Blueprint Patient Specific Instrumentation, Insignia |
| Sawtooth Surgical Solutions INC | $1,853.40 | 2024-2025 | |
| Arthrex, INC. | $1,699.00 | 2023-2025 | Shoulder Implants Fibertak Knotless, Shoulder Implants Biceps Repair Fibertak |
| Smith+Nephew, INC. | $1,512.55 | 2023-2025 | Q-Fix, Real Intelligence, Journey II |
| Prime Surgical, LLC | $1,213.93 | 2022-2023 | |
| Summit Surgical Corp. | $325.79 | 2023-2024 | |
| Depuy Synthes Sales INC. | $141.83 | 2023 | Healix Knotless Peek, Dynacord, Fms |
| Bioventus LLC | $81.73 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $19.83 | 2023 | Zilretta |
| Solventum Corporation | $18.54 | 2024 | Prevena |
| Heron Therapeutics, INC. | $17.03 | 2023 | Zynrelef |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Parker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.